Moghimani Minoo, Onyeaka Helen, Hashemi Mohammad, Afshari Asma
Department of Nutrition, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
School of Chemical Engineering, University of Birmingham, Edgbaston, United Kingdom.
Front Microbiol. 2024 Jun 5;15:1385301. doi: 10.3389/fmicb.2024.1385301. eCollection 2024.
Kefir beverage has beneficial microorganisms that have health-giving properties; therefore, they have a good potential to be probiotic. This study evaluated the probiotic potential, technological, and safety characteristics of , , and isolated from traditional kefir beverages.
First, isolates were evaluated in terms of resistance to acid, alkali, bile salts, trypsin, and pepsin of the gastrointestinal tract. The auto-aggregation and co-aggregation ability of isolates were measured using spectrophotometry. Antimicrobial activities were assayed against important food-borne pathogens using the agar well diffusion method. Moreover, gamma-aminobutyric acid (GABA) production was investigated by thin-layer chromatography (TLC).
Among the isolates, had an 85% total survival rate, but its amount reached below 6 log CFU/ml which is considered non-resistant, and it showed the highest auto-aggregation (74.67%). Moreover, only showed antimicrobial activity and had the highest co-aggregation with PTCC 1338 (54.33%) and ATCC 7644 (78%). Finally, an evaluation of the technological and safety characteristics of the strains showed that the strains produced GABA and were safe.
Although the isolates were not resistant to the gastrointestinal tract, their supernatant contained valuable natural compounds, including antioxidants, GABA, and antimicrobials, which can be used to produce functional foods and medicines. In addition, other approaches, such as increasing the initial number of strains, using foods as carriers of isolates, and encapsulating the isolates, can effectively increase the survivability of isolates in the gastrointestinal tract.
开菲尔饮料含有具有有益健康特性的微生物;因此,它们具有成为益生菌的良好潜力。本研究评估了从传统开菲尔饮料中分离出的[具体菌株名称1]、[具体菌株名称2]和[具体菌株名称3]的益生菌潜力、技术特性和安全性。
首先,从胃肠道的酸、碱、胆汁盐、胰蛋白酶和胃蛋白酶抗性方面对分离株进行评估。使用分光光度法测量分离株的自聚集和共聚集能力。采用琼脂扩散法测定对重要食源性病原体的抗菌活性。此外,通过薄层色谱法(TLC)研究γ-氨基丁酸(GABA)的产生。
在分离株中,[具体菌株名称1]的总存活率为85%,但其数量低于6 log CFU/ml,被认为不具有抗性,且其自聚集率最高(74.67%)。此外,只有[具体菌株名称2]表现出抗菌活性,并且与[菌株名称PTCC 1338]的共聚集率最高(54.33%),与[菌株名称ATCC 7644]的共聚集率为78%。最后,对这些菌株的技术和安全性特性评估表明,这些菌株产生GABA且是安全的。
尽管这些分离株对胃肠道不具有抗性,但其上清液含有有价值的天然化合物,包括抗氧化剂、GABA和抗菌剂,可用于生产功能性食品和药品。此外,其他方法,如增加菌株的初始数量、使用食物作为分离株的载体以及对分离株进行包封,可有效提高分离株在胃肠道中的存活率。